The novel therapy of this peptide represents a significant development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide257472.gynoblog.com/40773740/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment